Arvee Laboratories (India) Ltd. (NSE:ARVEE)

Market Cap	1.86B +14.9%
Revenue (ttm)	271.60M -28.9%
Net Income	20.75M -5.4%
EPS	1.88 -5.5%
Shares Out	11.02M
PE Ratio	89.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	720
Average Volume	2,904
Open	174.99
Previous Close	163.27
Day's Range	166.90 - 174.99
52-Week Range	129.11 - 290.78
Beta	0.58
RSI	57.06
Earnings Date	May 7, 2026

About NSE:ARVEE

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinit...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2012
• Employees: 70
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ARVEE

Financial Performance

In fiscal year 2025, NSE:ARVEE's revenue was 384.87 million, an increase of 26.83% compared to the previous year's 303.45 million. Earnings were 21.47 million, an increase of 104.15%.